CAS NO: | 912999-49-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Onalespib (AT13387) is a long-acting second-generationHsp90inhibitor with aKdof 0.71 nM. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Onalespib (Compound 35) is a potent inhibitor of Hsp90, with Kdof 0.71 nM. Onalespib shows potent antiproliferative activity in HCT116 cells, with an IC50of 31 nM. Onalespib also strongly inhibits the proliferation of a panel of human tumor cell lines, showing IC50of< 100 nM[1]. Onalespib exhibits cytotoxic activity against many of the PPTP cell lines, with median IC50of 41 nM[2]. | ||||||||||||||||
体内研究 (In Vivo) | Onalespib (60 mg/kg, ip 3 days on and 3 days off for four cycles) shows antitumor activity in nude BALB/c mice bearing early stage HCT116 human colon carcinoma xenografts[1]. Onalespib (40 or 60 mg/kg, i.p.) induces significant differences in EFS distribution compared to controls in 17% evaluable solid tumor xenografts, but in none of the ALL xenografts[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 409.52 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C24H31N3O3 | ||||||||||||||||
CAS 号 | 912999-49-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(122.09 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|